Delivery Order SPE2DB22D3301-SPE2DB24FY6NT

Award Date 5/10/24
Potential Completion Date 6/3/24
Potential Value $17K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,849.85 firm fixed-price delivery order contract is for the supply of OJJAARA 200 MG TABLET UU 30S, a medical product. The contract has an ultimate completion date of February 4, 2025 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,849.85, is a delivery order for OJJAARA 200 MG TABLET UU 30S. The contract is a firm fixed price agreement with a completion date of January 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,165.69 Firm Fixed Price Delivery Order is for the supply of 4564821265 OJJAARA 200 MG TABLET UU 30S, with a completion date of June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,849.85 firm fixed-price contract covers the delivery of OJJAARA 200 MG TABLET UU 30S medical products, with a performance period through March 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $34,331.38 Firm Fixed Price Delivery Order is for the supply of OJJAARA 200 MG TABLET UU 30S pharmaceutical products. The contract has no set-aside designation and has a period of performance through July 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) worth up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical sourcing and distribution company. The $17,212.75 order is for OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product, with a completion date of March 12, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,758.95 firm-fixed-price delivery order is for the supply of 4566598844 ! OJJAARA 200 MG TABLET UU 30S, with a period of performance through December 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $17,849.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 17, 2025. The contract covers the procurement of OJJAARA 200 MG TABLET medical products, which are likely used to support military treatment facilities, veterans' healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $17,165.69, is a Delivery Order for the supply of "OJJAARA 200 MG TABLET UU 30S" and does not have a set-aside designation. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a...
This federal contract award is a delivery order valued at $17,165.69 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The award was made by the Defense Logistics Agency (DLA), a defense agency, to provide 4565028708 - OJJAARA 200 MG TABLET UU 30S. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY6NT
    Delivery Order

This $17,165.69 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of OJJAARA 200 MG tablets, with an ultimate completion date of June 3, 2024.

Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award does not have a set-aside designation.

Generated 8/9/24, 9:04 AM